About BLFS

BioLife Solutions develops, manufactures and markets hypothermic storage and cryopreservation solutions and precision thermal shipping products for cloud-hosted logistics management applications for cells, tissues, and organs. BioLife also performs contract aseptic media formulation, fill, and finish services. The Company's proprietary HypoThermosol and CryoStor platform of solutions are highly valued in the biobanking, drug discovery, and regenerative medicine markets. BioLife's biopreservation media products are serum-free and protein-free, fully defined, and are formulated to reduce preservation-induced cell damage and death.BioLife's enabling technologies provides commercial companies and clinical researchers significant improvement in shelf life and post-preservation viability and function of cells, tissues, and organs. For more information please visit www.biolifesolutions.com
Primary Exchange: NASDAQ
SIC Surgical & Medical Instruments & Apparatus
NAICS Surgical Appliance and Supplies Manufacturing

BLFS is a Holding In These ETFs:

ETF Ticker ETF Name Net Assets Net Assets Raw # Holdings # Holdings Raw Weight Weight Raw Market Value Market Value Raw
PZI Invesco Zacks Micro Cap ETF 16.7 M 1.67E+07 400 400 0.38% 0.00378 63 K 62887
ITOT iShares Core S&P Total U.S. Stock Market ETF 18.5 B 1.85179E+10 3,573 3573 0.0% 0 118 K 118297
IWC iShares Microcap ETF 909.3 M 9.09255E+08 1,452 1452 0.03% 0.0003 291 K 290549

Wait, Before You Leave...